Venous Thromboembolism: Classification, Risk Factors, Diagnosis, and Management

Venous thromboembolism (VTE) is categorised as deep venous thrombosis (DVT) and pulmonary embolism (PE). VTE is associated with high morbidity and causes a huge financial burden on patients, hospitals, and governments. Both acquired and hereditary risks factors contribute to VTE. To diagnose VTE, noninvasive cost-effective diagnostic algorithms including clinical probability assessment and D-dimer measurement may be employed followup by compression ultrasonography for suspected DVT patients and multidetector computed tomography angiography for suspected PE patients. There are pharmacological and mechanical interventions to manage and prevent VTE. The pharmacological approaches mainly target pathways in coagulation cascade nonspecifically: conventional anticoagulants or specifically: new generation of anticoagulants. Excess bleeding is one of the major risk factors for pharmacological interventions. Hence, nonpharmacological or mechanical approaches such as inferior vena cava filters, graduated compression stockings, and intermittent pneumatic compression devices in combination with pharmacological interventions or alone may be a good approach to manage VTE.

[1]  B. Eriksson,et al.  Dose-escalation study of rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--for the prevention of venous thromboembolism in patients undergoing total hip replacement. , 2007, Thrombosis research.

[2]  P. Reitsma,et al.  Genetics of venous thrombosis , 2009, Journal of thrombosis and haemostasis : JTH.

[3]  F. Rosendaal,et al.  Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis , 2002, British journal of haematology.

[4]  S. Daeschner Pulmonary embolism. , 1988, Nursing.

[5]  J. Slattery,et al.  Thigh-Length Versus Below-Knee Stockings for Deep Venous Thrombosis Prophylaxis After Stroke , 2010, Annals of Internal Medicine.

[6]  J. Eikelboom,et al.  Latest medical treatment strategies for venous thromboembolism , 2007, Expert opinion on pharmacotherapy.

[7]  L. Mazzolai,et al.  Comparison of the diagnostic performance of the original and modified Wells score in inpatients and outpatients with suspected deep vein thrombosis. , 2011, Thrombosis research.

[8]  H. Partsch,et al.  Compression and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin. , 2000, Journal of vascular surgery.

[9]  G. Raskob,et al.  Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial , 2010, The Lancet.

[10]  D. W. Barritt,et al.  Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. , 1960, Lancet.

[11]  S. Frostick,et al.  Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial , 2007, Journal of thrombosis and haemostasis : JTH.

[12]  Kevin Weiss,et al.  Current pharmacologic treatment of dementia: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. , 2017, Annals of internal medicine.

[13]  V. Laux,et al.  Rivaroxaban: A New Oral Factor Xa Inhibitor , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[14]  J. Eikelboom,et al.  Update on Antithrombotic Therapy: New Anticoagulants , 2010, Circulation.

[15]  J. Vandenbroucke,et al.  Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis , 1995, The Lancet.

[16]  D. Wheatley,et al.  Venous thromboembolism prophylaxis guideline implementation is improved by nurse directed feedback and audit , 2011, Thrombosis journal.

[17]  M. Prins,et al.  Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: A randomized, controlled trial , 2005 .

[18]  S. Schoenberg,et al.  Venous thromboembolism: additional diagnostic value and radiation dose of pelvic CT venography in patients with suspected pulmonary embolism. , 2011, European journal of radiology.

[19]  Joseph A. Caprini Mechanical Methods for Thrombosis Prophylaxis , 2010, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[20]  E. Devine,et al.  Compression stockings to prevent post-thrombotic syndrome: a role for anticoagulation clinics? , 2007, Journal of Thrombosis and Thrombolysis.

[21]  M. Gent,et al.  Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double‐blind comparison , 2007, Journal of thrombosis and haemostasis : JTH.

[22]  P. Mannucci,et al.  Inherited thrombophilia: pathogenesis, clinical syndromes, and management. , 1996, Blood.

[23]  G. Raskob,et al.  Dose-Response Study of Recombinant Factor VIIa/Tissue Factor Inhibitor Recombinant Nematode Anticoagulant Protein c2 in Prevention of Postoperative Venous Thromboembolism in Patients Undergoing Total Knee Replacement , 2001, Circulation.

[24]  P. Sandercock,et al.  Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial , 2009, The Lancet.

[25]  M. O’Donnell,et al.  Graduated compression stockings to prevent venous thromboembolism in hospital: evidence from patients with acute stroke. , 2011, Polskie Archiwum Medycyny Wewnetrznej.

[26]  Pamela K Woodard,et al.  Multidetector computed tomography for acute pulmonary embolism. , 2006, The New England journal of medicine.

[27]  W. K. Ho Deep vein thrombosis--risks and diagnosis. , 2010, Australian family physician.

[28]  G. Raskob,et al.  Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. , 2010, The New England journal of medicine.

[29]  C. Mélot,et al.  Comparison of the Wells score with the simplified revised Geneva score for assessing pretest probability of pulmonary embolism. , 2011, Thrombosis research.

[30]  J. Hirsh,et al.  Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. , 2004, Chest.

[31]  S. Frostick,et al.  Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial , 2007, The Lancet.

[32]  B. Eriksson,et al.  Oral, direct Factor Xa inhibition with BAY 59‐7939 for the prevention of venous thromboembolism after total hip replacement , 2006, Journal of thrombosis and haemostasis : JTH.

[33]  Masaaki Ito,et al.  High Plasma Level of Factor VIII , 2011 .

[34]  C. O. Kennedy A controlled trial , 1971, British Homeopathic Journal.

[35]  C. Kearon,et al.  Natural History of Venous Thromboembolism , 2003, Circulation.

[36]  J. Heit,et al.  Risk factors for venous thromboembolism. , 2003, Clinics in chest medicine.

[37]  P. Monagle,et al.  Post-thrombotic syndrome , 2002, Archives of disease in childhood.

[38]  P. Wells,et al.  Diagnosis and treatment of deep-vein thrombosis , 2006, Canadian Medical Association Journal.

[39]  M. Gent,et al.  BAY 59‐7939: an oral, direct Factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose‐ranging study , 2005, Journal of thrombosis and haemostasis : JTH.

[40]  H. Büller,et al.  Fondaparinux or enoxaparin for initial treatment of symptomatic deep venous thrombosis: Randomized trial , 2004 .

[41]  D. Maclellan,et al.  MECHANICAL COMPRESSION IN THE PROPHYLAXIS OF VENOUS THROMBOEMBOLISM , 2007, ANZ journal of surgery.

[42]  Graeme J. Hankey Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial , 2009 .

[43]  Janet B. Long Venous Thromboembolism: Pharmacological and Nonpharmacological Interventions , 2009, The Journal of cardiovascular nursing.

[44]  Janis Bormanis,et al.  Value of assessment of pretest probability of deep-vein thrombosis in clinical management , 1997, The Lancet.

[45]  J. Douketis,et al.  Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. , 1998, JAMA.

[46]  D. Aujesky,et al.  Comparison of the revised Geneva score with the Wells rule for assessing clinical probability of pulmonary embolism , 2007, Journal of thrombosis and haemostasis : JTH.

[47]  M. Prins,et al.  Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose‐ranging study , 2008, Journal of thrombosis and haemostasis : JTH.

[48]  P. Romundstad,et al.  Incidence and mortality of venous thrombosis: a population‐based study , 2007, Journal of thrombosis and haemostasis : JTH.

[49]  J. Heit Venous thromboembolism: disease burden, outcomes and risk factors , 2005, Journal of thrombosis and haemostasis : JTH.

[50]  Sfedu Ep,et al.  [Acute pulmonary embolism. I]. , 2010, Cardiologia pratica.

[51]  M Gent,et al.  Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. , 2003, The New England journal of medicine.

[52]  Arnaud Perrier,et al.  Simplification of the revised Geneva score for assessing clinical probability of pulmonary embolism. , 2008, Archives of internal medicine.

[53]  M. Prins,et al.  Below-Knee Elastic Compression Stockings To Prevent the Post-Thrombotic Syndrome , 2004, Annals of Internal Medicine.

[54]  S. Eichinger,et al.  Novel Anticoagulants for the Prevention and Treatment of Venous Thromboembolism , 2003, Wiener Medizinische Wochenschrift.

[55]  T. Muneta,et al.  Doppler ultrasonography-aided early diagnosis of venous thromboembolism after total knee arthroplasty. , 2010, European Journal of Vascular and Endovascular Surgery.

[56]  A. Spyropoulos Managing Oral Anticoagulation Requires Expert Experience and Clinical Evidence , 2006, Journal of Thrombosis and Thrombolysis.

[57]  R. Clarke,et al.  Homocysteine, MTHFR and risk of venous thrombosis: a meta‐analysis of published epidemiological studies , 2005, Journal of thrombosis and haemostasis : JTH.

[58]  Jonathan Dreyer,et al.  Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. , 2003, The New England journal of medicine.

[59]  H. Bounameaux,et al.  Diagnosis of venous thromboembolism: an update , 2010, Vascular medicine.

[60]  L. Kwong Cost-effectiveness of rivaroxaban after total hip or total knee arthroplasty. , 2011, The American journal of managed care.

[61]  B. Eriksson,et al.  A Once-Daily, Oral, Direct Factor Xa Inhibitor, Rivaroxaban (BAY 59-7939), for Thromboprophylaxis After Total Hip Replacement , 2006, Circulation.